The heterogeneous nature of the mechanisms underlying neuropathic pain complicates the selection of appropriate treatments for individual patients. Although systematic reviews have outlined the ...
At present, the impact of the pharmacogenetics on the response to treatment in neuropathic pain is poorly known, but several polymorphisms, among them the cytochrome P450 (CYP)2D6, may intervene.
Find out about the groundbreaking MDMA clinical trial for chronic nerve pain. Discover how this study aims to test the impact of MDMA compared to a placebo.
Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
If you’re new to CBD, it’s best to start with ... needed before experts can conclude CBD is an effective treatment for nerve-related pain. The CBD world is filled with a lot of claims and ...
European researchers have mapped the most comprehensive phenotyping of neuropathic pain and identified ... improving patient quality of life and treatment outcomes. New research describes for ...
low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to new ...